Mylan (MYL) Shares Sold by Quinn Opportunity Partners LLC
Quinn Opportunity Partners LLC decreased its position in shares of Mylan (NASDAQ:MYL) by 52.1% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 56,600 shares of the company’s stock after selling 61,615 shares during the quarter. Quinn Opportunity Partners LLC’s holdings in Mylan were worth $2,395,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Lingohr & Partner Asset Management GmbH increased its holdings in shares of Mylan by 5.0% in the fourth quarter. Lingohr & Partner Asset Management GmbH now owns 22,979 shares of the company’s stock valued at $972,000 after purchasing an additional 1,100 shares during the period. Barings LLC increased its holdings in shares of Mylan by 9.1% in the third quarter. Barings LLC now owns 17,906 shares of the company’s stock valued at $562,000 after purchasing an additional 1,500 shares during the period. Amalgamated Bank increased its holdings in shares of Mylan by 3.4% in the third quarter. Amalgamated Bank now owns 61,264 shares of the company’s stock valued at $1,922,000 after purchasing an additional 1,991 shares during the period. Synovus Financial Corp increased its holdings in shares of Mylan by 7.1% in the fourth quarter. Synovus Financial Corp now owns 30,921 shares of the company’s stock valued at $1,309,000 after purchasing an additional 2,045 shares during the period. Finally, First Personal Financial Services increased its holdings in shares of Mylan by 77.1% in the fourth quarter. First Personal Financial Services now owns 4,839 shares of the company’s stock valued at $205,000 after purchasing an additional 2,106 shares during the period. 76.86% of the stock is currently owned by institutional investors.
Shares of Mylan (NASDAQ MYL) opened at $40.97 on Friday. The company has a current ratio of 1.13, a quick ratio of 0.95 and a debt-to-equity ratio of 0.97. The company has a market capitalization of $21,090.62, a price-to-earnings ratio of 8.98, a price-to-earnings-growth ratio of 1.10 and a beta of 1.35. Mylan has a 12-month low of $29.39 and a 12-month high of $47.82.
In other Mylan news, CEO Heather M. Bresch sold 75,000 shares of the business’s stock in a transaction on Tuesday, January 9th. The stock was sold at an average price of $45.00, for a total transaction of $3,375,000.00. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. 0.69% of the stock is currently owned by insiders.
MYL has been the topic of a number of recent research reports. Zacks Investment Research lowered Mylan from a “buy” rating to a “hold” rating in a report on Wednesday, November 8th. Cantor Fitzgerald set a $41.00 target price on Mylan and gave the company a “hold” rating in a report on Tuesday, December 26th. UBS Group set a $46.00 price objective on Mylan and gave the stock a “buy” rating in a report on Monday, December 4th. Susquehanna Bancshares reaffirmed a “positive” rating and set a $55.00 price objective (up previously from $47.00) on shares of Mylan in a report on Thursday, January 25th. Finally, BidaskClub raised Mylan from a “buy” rating to a “strong-buy” rating in a report on Tuesday, December 19th. Ten equities research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. Mylan presently has a consensus rating of “Buy” and an average target price of $45.37.
Mylan Company Profile
Mylan N.V. is a global pharmaceutical company. The Company develops, licenses, manufactures, markets and distributes generic and branded generic products for resale by others; specialty pharmaceuticals, and active pharmaceutical ingredients (APIs). It operates through two segments: Generics and Specialty.
Want to see what other hedge funds are holding MYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mylan (NASDAQ:MYL).
Receive News & Ratings for Mylan Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mylan and related companies with MarketBeat.com's FREE daily email newsletter.